<DOC>
	<DOC>NCT02662998</DOC>
	<brief_summary>The aim of this study is to validate uHear™, an iOS-based tool, as a screening tool to detect significant hearing impairment as part of a comprehensive geriatric assessment in patients aged 70 years and older. The pass or fail screening cut-off is defined as having two or more consecutive hearing grades starting from the moderate-severe threshold zone ranging from 0.5 - 2.0 kHz.</brief_summary>
	<brief_title>Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Older Cancer Patients Within a Comprehensive Geriatric Assessment - BIS</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<criteria>Patients should have reached the age of 70 or more at enrolment Histologically confirmed diagnosis of solid cancer or hematologic malignancy. All stages of cancer are eligible Patients should be fluent in Dutch or French Patients must receive their primary oncology care in the participating hospital Patients should be cognitively capable of performing the audiology assessment Patients should be scheduled to receive a CGA Patients should have signed informed consent Patients who do not match the above inclusion criteria Patients presenting with clinically diagnosed Meniere's disease, retrocochlear hearing loss, autoimmune inner ear disease, fluctuating hearing loss or a history of sudden sensory neural hearing loss Patients who already have a hearing aid or a previously diagnosed hearing loss</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>